Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...
Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas to be valued at eleven figures, the new funding round will bolster ...